DOCSLIB.ORG

Pre-Mrna Splicing in the New Millennium Michelle L Hastings and Adrian R Krainer*

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pre-Mrna Splicing in the New Millennium Michelle L Hastings and Adrian R Krainer* 302 Pre-mRNA splicing in the new millennium Michelle L Hastings and Adrian R Krainer* The past year has witnessed refinements in models of The subsequent association of the U4/U6U5 tri-snRNP with spliceosome assembly pathways and in the understanding of pre-mRNA results in formation of the B complex, and finally, how splicing factors of the serine/arginine-rich (SR) protein the C complex is formed by remodelling of RNA–RNA family function. The role of splicing in human genetic diseases and RNA–protein interactions to create the catalytically has also received a lot of attention recently as exonic splicing competent spliceosome. enhancers become better understood. Spliceosome assembly is facilitated, in part, by SR proteins, Addresses which are a family of splicing factors that have one or two Cold Spring Harbor Laboratory, 1 Bungtown Road, PO Box 100, Cold copies of an RNA-recognition motif (RRM) followed by an Spring Harbor, New York 11724-2208, USA arginine/serine-rich (RS) domain [2]. The RRMs mediate *e-mail: [email protected] RNA binding and determine substrate specificity for individ- Current Opinion in Cell Biology 2001, 13:302–309 ual SR proteins, whereas the RS domain appears to be required for protein–protein interactions. SR proteins have 0955-0674/01/$ — see front matter © 2001 Elsevier Science Ltd. All rights reserved. diverse roles in constitutive and alternative splicing. One such role is the recognition of exonic splicing enhancers (ESEs), Abbreviations which mediate splicing stimulation [3]. SR proteins act in a 3′ss 3′ splice site 5′ss 5′ splice site substrate-specific manner by binding to cognate ESEs, which BPS branch point sequence consist of degenerate sequence motifs. The degeneracy of ESE exonic splicing enhancer the consensus recognition motifs for SR proteins probably Py tract polypyrimidine tract allows overlap in binding, and specificity may result from RNAi RNA interference combinatorial effects, different SR protein levels, binding RRM RNA-recognition motif RS arginine/serine-rich affinities and specific interactions with other proteins. SR serine/arginine-rich U2AF U2 auxiliary factor The mechanisms by which the splicing machinery recog- nizes pre-mRNA have been the focus of several key studies Introduction in the past year, and these will be highlighted in this review. The precise removal of pre-mRNA introns is a critical The discovery of novel spliceosomal intermediates and aspect of gene expression. Not only must the splicing their implications for the mechanism of early splice-site machinery recognize and remove introns to make the cor- recognition will be discussed. Several studies that provide rect message for protein production but also, for many insights into the function of SR proteins in constitutive and genes, alternative splicing mechanisms must be in place to alternative splicing will also be reviewed. In addition, we generate functionally diverse protein isoforms in a spatially will describe reports that illustrate the physiological impor- and temporally regulated manner. The splicing reaction tance of alternative splicing and consequences of aberrant is carried out by the spliceosome, which consists of five splicing. Several topics not discussed here are addressed in small nuclear ribonucleoprotein complexes U1, U2, U4, recent reviews on alternative splicing [4,5], nuclear local- U5 and U6 snRNPs and a large number of non-snRNP pro- ization of splicing [6] and catalytic activity of the teins. The spliceosome acts through a multitude of spliceosome [1]. In addition, systematic analyses of RNA–RNA, RNA–protein and protein–protein interac- sequences from the entire Drosophila melanogaster [7] and tions to precisely excise each intron and join the exons in Schizosaccharomyces pombe [8] genomes allowed useful com- the correct order [1]. parisons of the human, yeast and fly splicing machinery. For efficient splicing, most introns require a conserved 5′ Rethinking spliceosome assembly splice site (5′ss), and a branch point sequence (BPS) followed The current model of spliceosome assembly proposes that by a polypyrimidine tract (Py tract) and a 3′ splice site (3′ss). U2 snRNP first associates with the pre-mRNA in an ATP- Assembly of the spliceosome onto pre-mRNA is an ordered dependent manner in the A complex. However, U2 process with several distinct intermediates. In metazoans, snRNP has now been identified as a component of a puri- current models hold that commitment of pre-mRNA to the fied, functional E complex [9••]. U2 snRNP association splicing pathway occurs upon ATP-independent formation of with the E complex occurs in the absence of ATP and the E complex. Assembly of the E complex involves recogni- does not require BPS interactions. The most straightfor- tion of the 5′ss by U1 snRNA base pairing and association of ward interpretation of the data is that the U2 snRNP first non-snRNP splicing factors, such as serine/arginine-rich (SR) binds loosely to the pre-mRNA in the E complex via the proteins and the U2 auxiliary factor (U2AF), which binds to integral U2 snRNP-associated protein SF3b, and then an the Py tract and 3′ss. Next, U2 snRNA base pairs with the ATP-dependent process leads to stable binding of U2 BPS during ATP-dependent formation of the A complex. snRNP to the BPS in the A complex (Figure 1). However, Pre-mRNA splicing in the new millennium Hastings and Krainer 303 Figure 1 mRNA Exon 1 GU A YYYYYYYYYY AG Exon 2 U2 U2snRNP snRNP SF3a SF3a SF3b SF3b U1 U1 snRNP snRNP ATP U2AF65 35 U2AF65 35 Exon 1 GU A YYYYYYYYYY AG Exon 2 Exon 1 GU A YYYYYYYYYY AG Exon 2 E complex Prp8 U4/U6•U5 U5 snRNP ATP U6 U4 U1 U2 U1 U2 snRNP snRNP snRNP snRNP U2AF65 35 U2AF65 35 Exon 1 GU A YYYYYYYYYY AG Exon 2 Exon 1 GU A YYYYYYYYYY AG Exon 2 A complex Prp8 U4/U6•U5 U5 snRNP U6 U4 Current Opinion in Cell Biology Intermediates in early spliceosome assembly. In the E complex, U1 consequence of tri-snRNP association with the pre-mRNA but probably snRNP binds at the 5′ss (red GU), and U2 snRNP loosely binds to the reflects a stabilization that occurs upon rearrangement of RNA–RNA pre-mRNA near the 3′ss (red AG) in an ATP-independent manner, interactions, including replacement of U1 by U6 at the 5′ss. A defined perhaps via interactions between SF3b and the U2AF heterodimer spliceosomal intermediate containing both the U1 snRNP and tri-snRNP, and/or U1 snRNP [9••]. In the presence of ATP, the U4/U6U5 tri- with or without U2 snRNP, has not been identified for the major splicing snRNP binds to the 5′ss region, in part through interactions between pathway, although evidence for an analogous interaction has been Prp8 and the pre-mRNA, and U2 snRNP stably binds to the BPS (single obtained for the U12-dependent pathway [13••]. Red vertical lines red A) [12••]. These two events can apparently occur independently (not indicate RNA base-pairing interactions, and filled circles and squares shoen). In this model, subsequent formation of the B complex is not a depict snRNA 5′ cap structures. under physiological conditions, in the presence of ATP, propose that U2 snRNP addition to the spliceosome does this temporal sequence may not be obligatory. not strictly require ATP but may be under the negative control of CUS2. Another study in yeast showed that the Similar to spliceosome assembly in higher eukaryotes, the requirement for the SUB2 ATPase could be bypassed by first ATP-dependent step in Saccharomyces cerevisiae deletion of the yeast homolog of U2AF65, MUD2 [11••]. pre-mRNA splicing also involves the stable binding of Both studies describe situations in which ATP-dependent U2 snRNP. Interestingly, in yeast extracts lacking the U2 steps in splicing can be bypassed, suggesting that some of suppressor protein, CUS2, a complex containing U2 the energy-requiring steps in splicing are not essential but snRNP can form in the absence of ATP [10••]. The authors may have evolved as regulatory checkpoints. 304 Nucleus and gene expression Figure 2 U4/U6U5 tri-snRNP both define the 5′ss before interac- tions with the 3′ss and U2 snRNP occur. Recognition of each splicing signal by multiple components is probably (a) RS very important for splicing fidelity. RRM U1 New findings from research on the U12-dependent AT-AC snRNP splicing pathway also provide clues to how the spliceosome 70K forms. An oligonucleotide displacement method allowed U2AF65 35 identification of U4atac–U6atac and U12–U6atac interac- tions that form without displacement of U11 by U6atac at GU A YYYYYYYY AG the 5′ss [13••]. However, the U12–U6atac–U4atac presump- Intron definition tive intermediate is not required for displacement of U11 (RS-domain-dependent) snRNP, suggesting that an alternative pathway for assembly of the minor spliceosome exists. This work also demon- (b) RS strates that the establishment of U6atac snRNA interactions with the 5′ss requires sequences within the 5′ exon and that RRM U2AF65 35 U5 and U6atac interact simultaneously with the pre-mRNA ′ GU A YRYRYRYY AG ESE near the 5 ss even in the absence of U12. These results are consistent with observations made with the U2-dependent Weak 3′ss/U2AF35-dependent splicing pathway ([12••] and references therein). (RS-domain-dependent) In addition to early spliceosome assembly, insights into the (c) second catalytic step of splicing have been reported recently, including the function of the adenine at the 3′ss ? [14] and the critical role of RNA helicase activity in yeast RRM I U2AF65 pre-mRNA splicing [15•]. In addition, the finding that GU A YYYYYYYYY AG ESE metal ion coordination by yeast U6 snRNA is required for splicing, provides strong evidence that U6 snRNA partici- Strong 3′ss/U2AF35-independent pates in splicing catalysis [16••].
Load more

Recommended publications
  • Control of Protein Function
    3 Control of Protein Function In the cell, precise regulation of protein function is essential to avoid chaos. This chapter describes the most important molecular mechanisms by which protein function is regulated in cells. These range from control of a protein’s location and lifetime within the cell to the binding of regulatory molecules and covalent modifications such as phosphorylation that rapidly switch protein activity on or off. Also covered here are the nucleotide-driven switches in conformation that underlie the action of motor proteins and that regulate many signal transduction pathways. 3-0 Overview: Mechanisms of Regulation 3-1 Protein Interaction Domains 3-2 Regulation by Location 3-3 Control by pH and Redox Environment 3-4 Effector Ligands: Competitive Binding and Cooperativity 3-5 Effector Ligands: Conformational Change and Allostery 3-6 Protein Switches Based on Nucleotide Hydrolysis 3-7 GTPase Switches: Small Signaling G Proteins 3-8 GTPase Switches: Signal Relay by Heterotrimeric GTPases 3-9 GTPase Switches: Protein Synthesis 3-10 Motor Protein Switches 3-11 Regulation by Degradation 3-12 Control of Protein Function by Phosphorylation 3-13 Regulation of Signaling Protein Kinases: Activation Mechanism 3-14 Regulation of Signaling Protein Kinases: Cdk Activation 3-15 Two-Component Signaling Systems in Bacteria 3-16 Control by Proteolysis: Activation of Precursors 3-17 Protein Splicing: Autoproteolysis by Inteins 3-18 Glycosylation 3-19 Protein Targeting by Lipid Modifications 3-20 Methylation, N-acetylation, Sumoylation and Nitrosylation 3-0 Overview: Mechanisms of Regulation Protein function in living cells is precisely regulated A typical bacterial cell contains a total of about 250,000 protein molecules (comprising different amounts of each of several thousand different gene products), which are packed into a volume so small that it has been estimated that, on average, they are separated from one another by a distance that would contain only a few molecules of water.
    [Show full text]
  • The PTB Interacting Protein Raver1 Regulates A-Tropomyosin Alternative Splicing
    The EMBO Journal Vol. 22 No. 23 pp. 6356±6364, 2003 The PTB interacting protein raver1 regulates a-tropomyosin alternative splicing Natalia Gromak, Alexis Rideau, alternative splicing, can be achieved by activation or Justine Southby, A.D.J.Scadden, inhibition (Smith and ValcaÂrcel, 2000; Caceres and Clare Gooding, Stefan HuÈ ttelmaier1, Kornblihtt, 2002). Spliceosome assembly can be assisted Robert H.Singer1 and by additional interactions of `SR' splicing factors with Christopher W.J.Smith2 splicing enhancer sequences, which are commonly found within exons (Blencowe, 2000; Cartegni et al., 2002). SR Department of Biochemistry, University of Cambridge, 80 Tennis proteins have a number of distinct roles in splicing and 1 Court Road, Cambridge CB2 1GA, UK and Department of Anatomy have been characterized as both constitutive and alterna- & Structural Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA tive splicing factors (Manley and Tacke, 1996; Graveley, 2000). A number of negative regulators have been 2 Corresponding author identi®ed, many of which are members of the hetero- e-mail: [email protected] geneous nuclear ribonucleoprotein (hnRNP) family Regulated switching of the mutually exclusive exons 2 (Krecic and Swanson, 1999; Smith and ValcaÂrcel, 2000; and3ofa-tropomyosin (TM) involves repression of Dreyfuss et al., 2002). These proteins contain RNA- exon 3 in smooth muscle cells. Polypyrimidine tract- binding domains as well as various accessory domains, but binding protein (PTB) is necessary but not suf®cient they do not contain the arginine-serine rich domains for regulation of TM splicing. Raver1 was identi®ed in characteristic of the SR family.
    [Show full text]
  • Differential Analysis of Gene Expression and Alternative Splicing
    i bioRxiv preprint doi: https://doi.org/10.1101/2020.08.23.234237; this version posted August 24, 2020. The copyright holder for this preprint i (which was not certified by peer review)“main” is the author/funder, — 2020/8/23 who has — granted 9:38 — bioRxiv page a1 license — #1 to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. i i EmpiReS: Differential Analysis of Gene Expression and Alternative Splicing Gergely Csaba∗, Evi Berchtold*,y, Armin Hadziahmetovic, Markus Gruber, Constantin Ammar and Ralf Zimmer Department of Informatics, Ludwig-Maximilians-Universitat¨ Munchen,¨ 80333, Munich, Germany ABSTRACT to translation. Different transcripts of the same gene are often expressed at the same time, possibly at different abundance, While absolute quantification is challenging in high- yielding a defined mixture of isoforms. Changes to this throughput measurements, changes of features composition are further referred to as differential alternative between conditions can often be determined with splicing (DAS). Various diseases can be linked to DAS high precision. Therefore, analysis of fold changes events (3). Most hallmarks of cancer like tumor progression is the standard method, but often, a doubly and immune escape (4, 5) can be attributed to changes in differential analysis of changes of changes is the transcript composition (6). DAS plays a prominent role required. Differential alternative splicing is an in various types of muscular dystrophy (MD) (7), splicing example of a doubly differential analysis, i.e. fold intervention by targeted exon removal is a therapeutic option changes between conditions for different isoforms in Duchenne MD (8).
    [Show full text]
  • Analysis of Exonic Mutations Leading to Exon Skipping in Patients with Pyruvate Dehydrogenase E1␣ Deficiency
    0031-3998/00/4806-0748 PEDIATRIC RESEARCH Vol. 48, No. 6, 2000 Copyright © 2000 International Pediatric Research Foundation, Inc. Printed in U.S.A. Analysis of Exonic Mutations Leading to Exon Skipping in Patients with Pyruvate Dehydrogenase E1␣ Deficiency ALESSANDRA KUPPER CARDOZO, LINDA DE MEIRLEIR, INGE LIEBAERS, AND WILLY LISSENS Center for Medical Genetics [A.K.C., L.D.M., I.L., W.L.] and Pediatric Neurology [L.D.M.], University Hospital, Vrije Universiteit Brussel, 1090 Brussels, Belgium. ABSTRACT The pyruvate dehydrogenase (PDH) complex is situated at a mutations that either reverted or disrupted the wild-type pre- key position in energy metabolism and is responsible for the dicted pre-mRNA secondary structure of exon 6, we were unable conversion of pyruvate to acetyl CoA. In the literature, two to establish a correlation between the aberrant splicing and unrelated patients with a PDH complex deficiency and splicing disruption of the predicted structure. The mutagenic experiments out of exon 6 of the PDH E1␣ gene have been described, described here and the silent mutation found in one of the although intronic/exonic boundaries on either side of exon 6 patients suggest the presence of an exonic splicing enhancer in were completely normal. Analysis of exon 6 in genomic DNA of the middle region of exon 6 of the PDH E1␣ gene. (Pediatr Res these patients revealed two exonic mutations, a silent and a 48: 748–753, 2000) missense mutation. Although not experimentally demonstrated, the authors in both publications suggested that the exonic muta- tions were responsible for the exon skipping. In this work, we Abbreviations were able to demonstrate, by performing splicing experiments, ESE, exonic splicing enhancer that the two exonic mutations described in the PDH E1␣ gene mfe, minimum free energy lead to aberrant splicing.
    [Show full text]
  • Enzyme-Catalyzed Expressed Protein Ligation
    ENZYME-CATALYZED EXPRESSED PROTEIN LIGATION by Samuel Henager A dissertation submitted to The Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland August, 2017 Abstract Expressed protein ligation involves the chemoselective reaction of recombinant protein thioesters produced via inteins with N-Cys containing synthetic peptides and has proved to be a valuable method for protein semisynthesis. Expressed protein ligation requires a cysteine residue at the ligation junction which can limit its use. Here we employ subtiligase, a re-engineered form of the protease subtilisin, to ligate a range of synthetic peptides, without the requirement of an N-terminal cysteine, to a variety of recombinant protein thioesters in rapid fashion. We have further broadened the scope of subtiligase-mediated protein ligations by employing a second-generation form (E156Q/G166K subtiligase) and a newly developed form (Y217K subtiligase) for ligation junctions with acidic residues. We have applied subtiligase-mediated expressed protein ligation to the generation of tetraphosphorylated, monophosphorylated, and non-phosphorylated forms of the tumor suppressor lipid phosphatase PTEN. In this way, we have demonstrated that the natural sequence around the ligation junction produced by subtiligase rather than cysteine-mediated ligation is necessary to confer the dramatic impact of tail phosphorylation on driving PTEN's closed conformation and reduced activity. We thus propose that subtiligase-mediated expressed protein ligation is an attractive traceless technology for precision analysis of protein post- translational modifications. Thesis Advisor: Dr. Philip Cole Second Reader: Dr. Jungsan Sohn ii To my family and friends, without whom none of this would have been possible.
    [Show full text]
  • Serine Arginine-Rich Protein-Dependent Suppression Of
    Serine͞arginine-rich protein-dependent suppression of exon skipping by exonic splicing enhancers El Che´ rif Ibrahim*, Thomas D. Schaal†, Klemens J. Hertel‡, Robin Reed*, and Tom Maniatis†§ *Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115; †Department of Molecular and Cellular Biology, Harvard University, 7 Divinity Avenue, Cambridge, MA 02138; and ‡Department of Microbiology and Molecular Genetics, University of California, Irvine, CA 92697-4025 Contributed by Tom Maniatis, January 28, 2005 The 5؅ and 3؅ splice sites within an intron can, in principle, be joined mechanisms by which exon skipping is prevented. Our data to those within any other intron during pre-mRNA splicing. How- reveal that splicing to the distal 3Ј splice site is suppressed by ever, exons are joined in a strict 5؅ to 3؅ linear order in constitu- proximal exonic sequences and that SR proteins are required for tively spliced pre-mRNAs. Thus, specific mechanisms must exist to this suppression. Thus, SR protein͞exonic enhancer complexes prevent the random joining of exons. Here we report that insertion not only function in exon and splice-site recognition but also play of exon sequences into an intron can inhibit splicing to the a role in ensuring that 5Ј and 3Ј splice sites within the same intron .downstream 3؅ splice site and that this inhibition is independent of are used, thus suppressing exon skipping intron size. The exon sequences required for splicing inhibition were found to be exonic enhancer elements, and their inhibitory Materials and Methods activity requires the binding of serine͞arginine-rich splicing fac- Construction of Plasmids.
    [Show full text]
  • NMR Evidence for an Unusual Peptide Bond at the N-Extein–Intein Junction
    Semisynthesis of a segmental isotopically labeled protein splicing precursor: NMR evidence for an unusual peptide bond at the N-extein–intein junction Alessandra Romanelli*†, Alexander Shekhtman†‡, David Cowburn‡, and Tom W. Muir*§ *Laboratory of Synthetic Protein Chemistry, The Rockefeller University, 1230 York Avenue, New York, NY 10021; and ‡New York Structure Biology Center, New York, NY 10027 Edited by Rowena G. Matthews, University of Michigan, Ann Arbor, MI, and approved March 9, 2004 (received for review October 13, 2003) Protein splicing is a posttranslational autocatalytic process in which (or O 3 N) acyl shift. This is known to be a spontaneous chemical an intervening sequence, termed an intein, is removed from a host rearrangement (10) and presumably does not require the intein. protein, the extein. Although we have a reasonable picture of the Although we have a reasonable overview of the various steps in basic chemical steps in protein splicing, our knowledge of how protein splicing, the mechanistic details of autocatalysis remain these are catalyzed and regulated is less well developed. In the poorly understood. There have been several high-resolution crystal current study, a combination of NMR spectroscopy and segmental structures of inteins (11–16) and related proteins (5, 7, 17). These isotopic labeling has been used to study the structure of an active structures have shed some light on the mechanism of the first step protein splicing precursor, corresponding to an N-extein fusion of in protein splicing, the N 3 S (or N 3 O) acyl shift. As illustrated ؊ 1 the Mxe GyrA intein. The JNC؅ coupling constant for the ( 1) in Fig.
    [Show full text]
  • In Silico Tools for Splicing Defect Prediction: a Survey from the Viewpoint of End Users
    © American College of Medical Genetics and Genomics REVIEW In silico tools for splicing defect prediction: a survey from the viewpoint of end users Xueqiu Jian, MPH1, Eric Boerwinkle, PhD1,2 and Xiaoming Liu, PhD1 RNA splicing is the process during which introns are excised and informaticians in relevant areas who are working on huge data sets exons are spliced. The precise recognition of splicing signals is critical may also benefit from this review. Specifically, we focus on those tools to this process, and mutations affecting splicing comprise a consider- whose primary goal is to predict the impact of mutations within the able proportion of genetic disease etiology. Analysis of RNA samples 5′ and 3′ splicing consensus regions: the algorithms used by different from the patient is the most straightforward and reliable method to tools as well as their major advantages and disadvantages are briefly detect splicing defects. However, currently, the technical limitation introduced; the formats of their input and output are summarized; prohibits its use in routine clinical practice. In silico tools that predict and the interpretation, evaluation, and prospection are also discussed. potential consequences of splicing mutations may be useful in daily Genet Med advance online publication 21 November 2013 diagnostic activities. In this review, we provide medical geneticists with some basic insights into some of the most popular in silico tools Key Words: bioinformatics; end user; in silico prediction tool; for splicing defect prediction, from the viewpoint of end users. Bio- medical genetics; splicing consensus region; splicing mutation INTRODUCTION TO PRE-mRNA SPLICING AND small nuclear ribonucleoproteins and more than 150 proteins, MUTATIONS AFFECTING SPLICING serine/arginine-rich (SR) proteins, heterogeneous nuclear ribo- Sixty years ago, the milestone discovery of the double-helix nucleoproteins, and the regulatory complex (Figure 1).
    [Show full text]
  • The Splicing Factor XAB2 Interacts with ERCC1-XPF and XPG for RNA-Loop Processing During Mammalian Development
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.20.211441; this version posted July 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The Splicing Factor XAB2 interacts with ERCC1-XPF and XPG for RNA-loop processing during mammalian development Evi Goulielmaki1*, Maria Tsekrekou1,2*, Nikos Batsiotos1,2, Mariana Ascensão-Ferreira3, Eleftheria Ledaki1, Kalliopi Stratigi1, Georgia Chatzinikolaou1, Pantelis Topalis1, Theodore Kosteas1, Janine Altmüller4, Jeroen A. Demmers5, Nuno L. Barbosa-Morais3, George A. Garinis1,2* 1. Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology- Hellas, GR70013, Heraklion, Crete, Greece, 2. Department of Biology, University of Crete, Heraklion, Crete, Greece, 3. Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal, 4. Cologne Center for Genomics (CCG), Institute for Genetics, University of Cologne, 50931, Cologne, Germany, 5. Proteomics Center, Netherlands Proteomics Center, and Department of Biochemistry, Erasmus University Medical Center, the Netherlands. Corresponding author: George A. Garinis ([email protected]) *: equally contributing authors bioRxiv preprint doi: https://doi.org/10.1101/2020.07.20.211441; this version posted July 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract RNA splicing, transcription and the DNA damage response are intriguingly linked in mammals but the underlying mechanisms remain poorly understood. Using an in vivo biotinylation tagging approach in mice, we show that the splicing factor XAB2 interacts with the core spliceosome and that it binds to spliceosomal U4 and U6 snRNAs and pre-mRNAs in developing livers.
    [Show full text]
  • RNA Components of the Spliceosome Regulate Tissue- and Cancer-Specific Alternative Splicing
    Downloaded from genome.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Research RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing Heidi Dvinge,1,2,4 Jamie Guenthoer,3 Peggy L. Porter,3 and Robert K. Bradley1,2 1Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA; 2Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA; 3Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA Alternative splicing of pre-mRNAs plays a pivotal role during the establishment and maintenance of human cell types. Characterizing the trans-acting regulatory proteins that control alternative splicing has therefore been the focus of much research. Recent work has established that even core protein components of the spliceosome, which are required for splicing to proceed, can nonetheless contribute to splicing regulation by modulating splice site choice. We here show that the RNA components of the spliceosome likewise influence alternative splicing decisions. Although these small nuclear RNAs (snRNAs), termed U1, U2, U4, U5, and U6 snRNA, are present in equal stoichiometry within the spliceosome, we found that their relative levels vary by an order of magnitude during development, across tissues, and across cancer samples. Physiologically relevant perturbation of individual snRNAs drove widespread gene-specific differences in alternative splic- ing but not transcriptome-wide splicing failure. Genes that were particularly sensitive to variations in snRNA abundance in a breast cancer cell line model were likewise preferentially misspliced within a clinically diverse cohort of invasive breast ductal carcinomas.
    [Show full text]
  • An Exon That Prevents Transport of a Mature Mrna
    Proc. Natl. Acad. Sci. USA Vol. 96, pp. 3813–3818, March 1999 Genetics An exon that prevents transport of a mature mRNA MARGARET A. MACMORRIS*, DIEGO A. R. ZORIO*†, AND THOMAS BLUMENTHAL*‡ *Department of Biochemistry and Molecular Genetics, University of Colorado Health Sciences Center, Denver, CO 80262; and †Department of Biology, Indiana University, Bloomington, IN 47405 Communicated by William B. Wood III, University of Colorado, Boulder, CO, January 25, 1999 (received for review November 18, 1998) ABSTRACT In Caenorhabditis elegans, pre-mRNA for the recognizes (6). Here we show that uaf-1 exon 3-containing essential splicing factor U2AF65 sometimes is spliced to pro- RNA is not subject to Smg-mediated decay in spite of its duce an RNA that includes an extra 216-bp internal exon, exon containing a PTC. Although it is not yet understood how the 3. Inclusion of exon 3 inserts an in-frame stop codon, yet this components of the pathway act to recognize and degrade RNA is not subject to SMG-mediated RNA surveillance. To aberrant mRNAs, Smg is likely to operate at the site of protein test whether exon 3 causes RNA to remain nuclear and thereby synthesis. Because the yeast homolog of SMG-2, UPF1, has escape decay, we inserted it into the 3* untranslated region of been localized to the cytoplasm at the site of polyribosomes a gfp reporter gene. Although exon 3 did not affect accumu- (7), an mRNA that fails to leave the nucleus might well be lation or processing of the mRNA, it dramatically suppressed unaffected by the Smg pathway.
    [Show full text]
  • The Differential Interaction of Snrnps with Pre-Mrna Reveals Splicing Kinetics in Living Cells
    Published October 4, 2010 This article has original data in the JCB Data Viewer JCB: Article http://jcb-dataviewer.rupress.org/jcb/browse/3011 The differential interaction of snRNPs with pre-mRNA reveals splicing kinetics in living cells Martina Huranová,1 Ivan Ivani,1 Aleš Benda,2 Ina Poser,3 Yehuda Brody,4,5 Martin Hof,2 Yaron Shav-Tal,4,5 Karla M. Neugebauer,3 and David StanČk1 1Institute of Molecular Genetics and 2J. Heyrovský Institute of Physical Chemistry, Academy of Sciences of the Czech Republic, 142 20 Prague, Czech Republic 3Max Planck Institute for Molecular Cell Biology and Genetics, 01307 Dresden, Germany 4The Mina and Everard Goodman Faculty of Life Sciences and 5Institute for Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan 52900, Israel recursor messenger RNA (pre-mRNA) splicing is Core components of the spliceosome, U2 and U5 snRNPs, catalyzed by the spliceosome, a large ribonucleo- associated with pre-mRNA for 15–30 s, indicating that protein (RNP) complex composed of five small nuclear splicing is accomplished within this time period. Additionally, P Downloaded from RNP particles (snRNPs) and additional proteins. Using live binding of U1 and U4/U6 snRNPs with pre-mRNA oc- cell imaging of GFP-tagged snRNP components expressed curred within seconds, indicating that the interaction of at endogenous levels, we examined how the spliceosome individual snRNPs with pre-mRNA is distinct. These results assembles in vivo. A comprehensive analysis of snRNP are consistent with the predictions of the step-wise model dynamics in the cell nucleus enabled us to determine of spliceosome assembly and provide an estimate on the snRNP diffusion throughout the nucleoplasm as well as rate of splicing in human cells.
    [Show full text]